المؤلفون: van der Ploeg, C. P B, van den Akker-van Marle, M. E., Vernooij-van Langen, A. M M, Elvers, L. H., Gille, J. J P, Verkerk, P. H., Dankert-Roelse, J. E., Loeber, J. G., Triepels, R. H., Van der Ploeg, C. P B, van der Pal, S. M., Dompeling, E., Pals, G., van den Akker van Marle, M. E., Gulmans, V. A M, Oey-Spauwen, M. J W, Wijnands, Y. H H M, Castricum, L. M., Arets, H. G M, van der Ent, C. K., Tiddens, H. A W M, de Rijke, Y. B., Yntema, J. B.

المساهمون: Kindergeneeskunde, RS: CAPHRI School for Public Health and Primary Care, RS: CAPHRI - R5 - Optimising Patient Care, Public Health, Human genetics, CCA - Disease profiling

المصدر: Journal of Cystic Fibrosis, 14(2), 194-202
van der Ploeg, C P B, van den Akker-v Marie, ME, Vernooij-van Langen, A M M, Elvers, L H, Gille, J J P, Verkerk, P H & Dankert-Roelse, J E 2015, ' Cost-effectiveness of newborn screening for cystic fibrosis determined with real-life data ', Journal of Cystic Fibrosis, vol. 14, no. 2, pp. 194-202 . https://doi.org/10.1016/j.jcf.2014.08.007
Journal of Cystic Fibrosis, 14(2), 194. Elsevier
Journal of Cystic Fibrosis, 14(2), 194-202. Elsevier Science
Journal of Cystic Fibrosis, 14(2), 194-202. Elsevier

مصطلحات موضوعية: Pulmonary and Respiratory Medicine, Newborn screening, Pediatrics, medicine.medical_specialty, Cost effectiveness, Genetic counseling, Cost-Benefit Analysis, Cystic Fibrosis Transmembrane Conductance Regulator, Pancreatitis-Associated Proteins, Research Support, Sensitivity and Specificity, behavioral disciplines and activities, Cystic fibrosis, Decision Support Techniques, Neonatal Screening, SDG 3 - Good Health and Well-being, Antigens, Neoplasm, medicine, Biomarkers, Tumor, Journal Article, Humans, Lectins, C-Type, Comparative Study, Genetic Testing, Pediatrics, Perinatology, and Child Health, Non-U.S. Gov't, Sweat test, Netherlands, medicine.diagnostic_test, business.industry, Public health, Research Support, Non-U.S. Gov't, Infant, Newborn, Cost-effectiveness analysis, Perinatology, Quality-adjusted life year, and Child Health, Pediatrics, Perinatology and Child Health, Mutation, Trypsinogen, Cost-effectiveness, business, Decision analysis

وصف الملف: image/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25cbac0fa3ee8eb5c4763af31dde60ea
http://hdl.handle.net/1887/108027